Back to search
Severely Burned Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Severely Burned Patients trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Severely Burned Patients trials you may qualify forCefiderocol is a powerful, broad spectrum antibiotic approved to treat hospital-acquired or ventilator associated pneumonia and urinary tract infections. Althou…
Hemodynamic management has long been identified as a key factor affecting burn prognosis. However, large amounts of crystalloid infusion have been associated wi…
The aim of this study is to longitudinally monitor dynamic changes in the gut microbiome following severe burn injury using fecal samples. Under standard nutrit…
This study enrolls approximately 270 adult patients with severe burns covering at least 20% of total body surface area to evaluate how well the blood biomarker…
The purpose of this observational study is to examine whether Endotheliopathy of Trauma (EoT) is present in severely burned patients and how it is affected by b…
Approximately 33 to 91% of severe burn victims will develop hypertrophic scars. Hypertrophic scars are defined as erythematous (red), raised and rigid scars tha…
The Swisskera project is a multicenter follow-up study at the three Swiss burn centers evaluating long-term outcomes after burn wound coverage with lab-grown ep…
This retrospective observational study aims to investigate the clinical outcomes of critically ill burn patients who underwent continuous renal replacement ther…